Survey of current prenatal screening for Down syndrome in Australian hospitals providing maternity care

被引:6
|
作者
Lawrence, K [1 ]
Crowther, CA [1 ]
机构
[1] Univ Adelaide, Dept Obstet & Gynaecol, Womens & Childrens Hosp, Adelaide, SA 5001, Australia
关键词
Down syndrome; maternal serum screening; nuchal translucency screening; screening tests;
D O I
10.1046/j.0004-8666.2003.00071.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The present study assessed the screening tests for Down syndrome available to women within Australian hospitals. Methods: Postal questionnaires. Results: A total of 282 (57%) hospitals responded with over two-thirds offering some form of screening test which varied by geographical region and level of institution. First trimester maternal serum screening was offered by 11% of hospitals. Nuchal translucency screening was offered by 52% of hospitals with higher use in Australian Capital Territory and New South Wales than in the other regions. Second trimester maternal serum screening was offered by 75% of hospitals with higher rates in Australian Capital Territory, South Australia and the lowest rate in Queensland. Conclusions: A high proportion of women are offered screening but with wide variation in the tests used.
引用
收藏
页码:222 / 225
页数:4
相关论文
共 50 条
  • [41] Proteomic techniques for finding biomarkers for prenatal screening for Down syndrome: where are we?
    Wang, Qiu-Wei
    Yu, Bin
    EXPERT REVIEW OF PROTEOMICS, 2012, 9 (06) : 583 - 585
  • [42] Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey
    Okem, Zeynep Culdem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, M. Sinan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 219 : 40 - 44
  • [43] Analysis of Down syndrome failed to be diagnosed after prenatal screening A multicenter study
    Jiang, Tao
    Ding, Jie
    Zhang, Xiao-Qing
    Zhang, Xiao-Juan
    Zhang, Bin
    Wang, Ting
    Yu, Bin
    MEDICINE, 2017, 96 (24)
  • [44] Prenatal screening for Down's syndrome using inhibin-A as a serum marker
    Wald, NJ
    Densem, JW
    George, L
    Muttukrishna, S
    Knight, PG
    PRENATAL DIAGNOSIS, 1996, 16 (02) : 143 - 153
  • [45] Fluorescence in situ hybridization of chorionic interphase cells for prenatal screening of Down syndrome
    Tóth, A
    Tardy, EP
    Hajdu, K
    Bátorfi, J
    Doszpod, J
    Egyed, J
    Gáti, I
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 94 (01) : 46 - 50
  • [46] Maternal serum screening for Down syndrome in the United States: A 1995 survey
    Palomaki, GE
    Knight, GJ
    McCarthy, JE
    Haddow, JE
    Donhowe, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (05) : 1046 - 1051
  • [47] Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes
    Smith-Bindman, R
    Chu, P
    Bacchetti, P
    Waters, JJ
    Mutton, D
    Alberman, E
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) : 980 - 985
  • [48] From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan
    Shaw, S. W. Steven
    Chen, Chih-Ping
    Cheng, Po-Jen
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (04): : 470 - 474
  • [49] Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective
    Schoonen, Marleen
    van der Zee, Boukje
    Wildschut, Hajo
    de Beaufort, Inez
    de Wert, Guido
    de Koning, Harry
    Essink-Bot, Marie-Louise
    Steegers, Eric
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (03) : 485 - 497
  • [50] Uptake of Noninvasive Prenatal Testing in Chinese Women following Positive Down Syndrome Screening
    Poon, C. F.
    Tse, W. C.
    Kou, K. O.
    Leung, K. Y.
    FETAL DIAGNOSIS AND THERAPY, 2015, 37 (02) : 141 - 147